Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald B Appel

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
American Journal of Nephrology|March 31, 2021
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport SyndromeGlenn M Chertow, Gerald B Appel, Sharon Andreoli, et al.
Glomerular Diseases|April 22, 2022
Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney AllograftCatherine R Kavanagh, Francesca Zanoni, Rita Leal, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathyNatalia Papeta, Krzysztof Kiryluk, Ami Patel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
The classification of glomerulonephritis in systemic lupus erythematosus revisitedJan J Weening, Vivette D D'Agati, Melvin M Schwartz, et al.
Kidney International|January 14, 2004
The classification of glomerulonephritis in systemic lupus erythematosus revisitedJan J Weening, Vivette D D'Agati, Melvin M Schwartz, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 21, 2022
Effects of Bardoxolone Methyl in Alport SyndromeBradley A Warady, Pablo E Pergola, Rajiv Agarwal, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
American Journal of Nephrology|March 31, 2021
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport SyndromeGlenn M Chertow, Gerald B Appel, Sharon Andreoli, et al.
Glomerular Diseases|April 22, 2022
Clinical Predictors and Prognosis of Recurrent IgA Nephropathy in the Kidney AllograftCatherine R Kavanagh, Francesca Zanoni, Rita Leal, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathyNatalia Papeta, Krzysztof Kiryluk, Ami Patel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
The classification of glomerulonephritis in systemic lupus erythematosus revisitedJan J Weening, Vivette D D'Agati, Melvin M Schwartz, et al.
Kidney International|January 14, 2004
The classification of glomerulonephritis in systemic lupus erythematosus revisitedJan J Weening, Vivette D D'Agati, Melvin M Schwartz, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 21, 2022
Effects of Bardoxolone Methyl in Alport SyndromeBradley A Warady, Pablo E Pergola, Rajiv Agarwal, et al.
Pageof 14